Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
amgen
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eteplirsen
2
×
gene therapy
glaxosmithkline
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
adverum biotechnologies
albert bourla
What
bio
roundup
acquisitions
albert
august
biggest
biotech
bourla
busy
ceo
company
crispr
days
decisions
devices
drug
drugs
fda
future
imports
legacy
maker
maps
measured
news
nods
opioid
past
patients
pfizer
pfizer’s
regulatory
revenue
sarepta’s
seven
shkreli’s
slow
stumble
suits
tends
Language
unknown
unset
Current search:
eteplirsen
×
glaxosmithkline
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More